MedTrace Logo

Evaluation of Coagulation Status of Pregnant Women in the Peripartum Period Using the Device Clotpro®

NCT05935137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2025-04-24

No results posted yet for this study

Summary

The primary aim of the study is to determine the physiological parameters of the coagulation status of pregnant women in the peripartum period (PWPP) for the ClotPro® device - Ex-test (CT, CFT, MCF, A5, A10, A20, ML), In-test (CT, CFT, MCF, A5, A10, A20, ML) and Fib-test (CT, CFT, MCF, A5, A10, A20, ML) and based on these results, establish ClotPro® reference ranges in parturients. The secondary aim is to compare the difference in coagulation parameters between pregnant women in the peripartum period and a control group of non-pregnant women (NPW) on the ClotPro® device. Furthermore, a comparison with the physiological parameters of pregnant women in the peripartum period intended for ROTEM® and TEG® devices (they are already known).

Conditions

  • Coagulation and Hemorrhagic Disorders

Interventions

DIAGNOSTIC_TEST

Coagulation test on device ClotPro

The blood sample for coagulation test on device ClotPro will be take for both group and the test will be provided.

Sponsors & Collaborators

  • Ondrej Hrdy

    lead OTHER

Principal Investigators

  • Roman Gal, prof · University Hospital Brno

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-26
Primary Completion
2024-01-17
Completion
2024-01-17

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05935137 on ClinicalTrials.gov